Gastric Cancer Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
Nexatin - Injection
Used as treatment or post-surgery adjuvant therapy for metastatic colorectal cancer, colon cancer, advanced or metastatic gastric cancer, and stage II and III ...
CONTACT SUPPLIER -
Manufacturerbased in Shanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius HANQUYOU - Trastuzumab
??? (trastuzumab, Zercepac in the EU) was successfully launched in China and Europe, becoming the first Chinese mAb biosimilar entering both the EU and China market. It is indicated for the treatment of HER2 positive early breast ...
CONTACT SUPPLIER -
Manufacturerbased in Munich, GERMANY
ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic ...
ImevaX - CagA Antigen - Cytotoxin-Associated Antigen A
(cytotoxin-associated antigen A) is one of the best studied and most important virulence factors. Subjects infected with H. pylori strains expressing CagA have a significant higher risk to develop complications, including gastric ...
CONTACT SUPPLIER -
Manufacturerbased in Malmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Oncoral - Novel Daily Irinotecan Chemotherapy Agent
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet with the potential ...
CONTACT SUPPLIER -
Manufacturerbased in Dunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
Cxcolorectal - Urine Sampling System
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment ...
CONTACT SUPPLIER -
Manufacturerbased in Chatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
Tonix - Model TNX-1700 - Gastric and Colorectal Cancers Antibody
TNX-1700 is a stabilized recombinant version of Trefoil Factor 2 (TFF2) and is being developed by Tonix as a biologic to treat gastric and colorectal cancers. TFF2 is a small, secreted protein, encoded by the TFF2 ...
CONTACT SUPPLIER -
Manufacturerbased in Woodland Hills, CALIFORNIA (USA)
EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...
EntroGen - Model PI3K-RT48 - PIK3CA Mutation Analysis Kit for Real-Time PCR
, gliomas, gastric cancer, breast cancer, endometrial cancer, and lung cancer. PIK3CA mutations commonly occur in exon 9, which encodes the helical domain and exon ...
CONTACT SUPPLIER -
Manufacturerbased in Shanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
Model ES028 - Bispecific Macrophage Engager (BiME) Platform
for potent activation of phagocytosis and directly kill tumor cells for treatment of solid tumors. We expect to develop ES028 as a monotherapy to provide an “eat-me” signal that can induce full activation of macrophage phagocytosis ...
CONTACT SUPPLIER -
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Model 820TCR - Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1)
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. T-Cure estimates that KK-LC-1 is ...
CONTACT SUPPLIER -
Manufacturerbased in Hawthorne, CALIFORNIA (USA)
Intramedical Imaging develops, manufactures, and markets a series of molecular imaging instruments to detect cancer during surgery. Molecular imaging is the most sensitive method of identifying abnormal tissues. The widespread application of ...
Intramedical - Model WG-140L - Laproscopic Gamma Probe
Available Tip Sizes: 5mm, 10mm; Node Biopsy/Mapping in Cervical, Prostate and Gastric ...
CONTACT SUPPLIER -
Technologybased in Yongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Vivozon - Model PT-VVZ149-04 - Analgesic Efficacy and Safety of VVZ-149 Injection
A randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the analgesic efficacy and safety of VVZ-149 Injection in patients who have pain after laparoscopic gastrectomy in early gastric ...
CONTACT SUPPLIER -
Manufacturerbased in Balerna, SWITZERLAND
PRIMA Lab SA, modern Swiss Company in the diagnostic field, develops the core of its innovation offering simple and efficient devices CE certified, for a quick check-up of human and animal’s health conditions. Thanks to its complete range of tests, ...
Helicobacter Pylori Antigen Faecal Test
if fasting or in the early morning, when the stomach is empty. Other associated symptoms include nausea, satiety, reflux, loss of appetite, burping, weight loss and diarrhoea. Ulcers can sometimes bleed, causing anaemia over long periods of time. ...
CONTACT SUPPLIER -
Manufacturerbased in HENFIELD, UNITED KINGDOM
A trusted and established manufacturer of gamma probe systems. Since 1986 Care Wise have been a trusted and established manufacturer of gamma probe systems. Previously based in Morgan Hill, CA, USA, the company has always been at the forefront of ...
Care Wise - Model OmniProbe EL - Gamma Probe for Laparoscopic Applications
Designed for Laparoscopic Applications such as Cervical, Prostate and Gastric Cancer. ...
CONTACT SUPPLIER -
Manufacturerbased in Baldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
MicOryx - Model MSI - Therapeutic Vaccine
are constantly expressed. Cancers with MSI-H mutations include 10-15 % of colorectal cancers, 20-25 % of endometrial cancers, 25-30 % of upper urinary tract cancers, 15-20 % of ...
CONTACT SUPPLIER -
Manufacturerbased in Princeton, NEW JERSEY (USA)
Taiho Oncology, Inc. specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a ...
Futibatinib - Model FGFR 1-4 - Inhibitor
Tumors with specific FGFR aberrations: Solid tumors, Gastric cancer, Myelolymphoid neoplasms PHASE ...
CONTACT SUPPLIER -
Manufacturerbased in Seville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
Signal - Model X - Multi-Cancer Platform
We are developing Signal-X, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. ...
CONTACT SUPPLIER -
Manufacturerbased in Sarıyer, TURKEY
Virasoft Inc. was founded in 2015 with the support of the Turkish Ministry of Industry and Technology. We develop institution-specific projects in 4 main areas that meet all the needs of an institution in digital pathology. We focus on four main ...
Virasoft - Model HER2 - Epidermal Growth Factor Receptor 2
The HER2 gene is an oncogene encoding the “Epidermal Growth Factor Receptor 2” which is a transmembrane glycoprotein. Amplification of the HER2 gene and overexpression of HER2 receptor on the cell membrane is observed in approximately ...
CONTACT SUPPLIER -
Manufacturerbased in Oxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
ImmunoBody - Model SCIB2 & iSCIB2 - Cancer Vaccine
SCIB2 is the second cancer vaccine based on the ImmunoBody® technology and encodes a modified antibody engineered to express the cancer antigen NY-ESO-1. This is a well-characterised and validated ...
CONTACT SUPPLIER -
Technologybased in Vancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Zanidatamab - Bispecific Antibody
Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as ...
CONTACT SUPPLIER -
Manufacturerbased in Heidelberg, GERMANY
We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ ...
Affimed - Model AFM13 - Innate Cell Engager Molecule
Lighting the way with clinical results: we are creating success with monotherapies and combination therapies. AFM13, a first-in-class ICE (innate cell engager) molecule targeting patients with CD30-positive lymphomas,4 showed antitumor responses in ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you